Growth Metrics

Pacific Biosciences Of California (PACB) EBIT Growth (1y) (2011 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (1y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn -20.56%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 11.83%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -11.06%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 19.54%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 20.97%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 74.18%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 90.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -18.12%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 46.60%
10 Pacific Biosciences Of California 481.66 Mn 205.70 Mn 12.84 Mn 98.05%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 98.05%
Dec 31, 2025 73.08%
Sep 30, 2025 39.33%
Jun 30, 2025 74.49%
Mar 31, 2025 -427.19%
Dec 31, 2024 -74.79%
Sep 30, 2024 22.32%
Jun 30, 2024 -140.31%
Mar 31, 2024 10.84%
Dec 31, 2023 -0.53%
Sep 30, 2023 -10.55%
Jun 30, 2023 -7.66%
Mar 31, 2023 -17.71%
Dec 31, 2022 -34.65%
Jun 30, 2022 -80.90%
Mar 31, 2022 -129.97%
Dec 31, 2021 -169.74%
Jun 30, 2021 -59.72%
Mar 31, 2021 -3.06%
Dec 31, 2020 -33.82%
Sep 30, 2020 14.01%
Jun 30, 2020 3.51%
Mar 31, 2020 -8.55%
Dec 31, 2019 41.49%
Sep 30, 2019 -13.96%
Jun 30, 2019 -12.12%
Mar 31, 2019 -25.83%
Dec 31, 2018 -49.17%
Sep 30, 2018 -14.38%
Jun 30, 2018 10.83%
Mar 31, 2018 -2.79%
Dec 31, 2017 -14.85%
Sep 30, 2017 -28.89%
Jun 30, 2017 -34.96%
Mar 31, 2017 -25.50%
Dec 31, 2016 -1,583.05%
Sep 30, 2016 -740.21%
Jun 30, 2016 -59.09%
Mar 31, 2016 3.95%
Dec 31, 2015 94.07%
Sep 30, 2015 131.07%
Jun 30, 2015 37.94%
Mar 31, 2015 -5.94%
Dec 31, 2014 -5.23%
Sep 30, 2014 57.80%
Jun 30, 2014 8.48%
Mar 31, 2014 11.46%
Dec 31, 2013 21.62%
Sep 30, 2013 11.71%
Jun 30, 2013 11.34%
Mar 31, 2013 25.09%
Dec 31, 2012 4.39%
Sep 30, 2012 23.30%
Jun 30, 2012 0.48%
Mar 31, 2012 21.33%
Dec 31, 2011 37.99%
Sep 30, 2011 27.67%
Jun 30, 2011 30.64%